FEDERALhearing transcript

Senate Hearing on Gene Editing Technology: Innovation and Impact

Original title: GENE EDITING TECHNOLOGY: INNOVATION AND IMPACT

January 1, 2019

biotechnology gene editing CRISPR medical research bioethics healthcare innovation

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing explores the regulatory and ethical landscape for technology, which could fundamentally change how medical conditions like sickle cell anemia are treated in the future.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medical Research Community

Researchers utilize CRISPR as a primary tool for genetic experimentation and disease treatment development.

Agricultural Industry

The industry uses gene-editing technology to develop crops with specific traits, such as disease resistance.

Patients with Genetic Diseases

Individuals with conditions like sickle cell anemia are the potential recipients of therapies developed through gene-editing research.

What changed

Last recorded activity January 1, 2019.

What's next

Next step not available in the current record.

Summary

This document is a transcript from a 2017 Senate Health, Education, Labor, and Pensions Committee hearing regarding the potential and ethical implications of gene-editing technologies like . Experts and lawmakers discussed how these tools can be used to treat diseases, their accessibility compared to older methods, and the broader societal impacts of genetic modification.

Key Facts

CRISPR technology functions by using molecules to locate, cut, and edit specific genes, similar to a 'cut and paste' function in a computer document.
CRISPR was developed in 1993 and perfected for human application in 2013.
CRISPR is noted for being less expensive, more precise, and more accessible to global scientists than previous gene-editing methods.
The technology has been applied to agriculture to create disease-resistant wheat and rice.
Medical research applications include potential treatments for sickle cell anemia.
The hearing included testimony from experts in pediatrics, biotechnology, and bioethics.

Frequently Asked Questions

What is CRISPR?

is a gene-editing technology that acts like molecular scissors to find, cut, and repair or replace mutated genes.

How is CRISPR different from older gene-editing tools?

It is described as being more precise, less expensive, and more widely available to researchers than previous technologies.

Why It Matters

The hearing explores the regulatory and ethical landscape for technology, which could fundamentally change how medical conditions like sickle cell anemia are treated in the future.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Early Congressional Interest in CRISPR

The hearing demonstrates that as early as 2017, the Senate was actively engaging with the ethical and practical implications of CRISPR, signaling a proactive approach to emerging biotech regulation.

Committee on Health, Education, Labor, and Pensions

Connected Entities

organizationCommittee on Health, Education, Labor, and Pensions“Senate committee conducting the hearing”Map →

personMatthew Porteus“Associate Professor of Pediatrics, Stanford University”Map →

personLamar Alexander“Chairman of the Committee on Health, Education, Labor, and Pensions”Map →

personPatty Murray“U.S. Senator from Washington”Map →

personKatrine Bosley“CEO and President, Editas Medicine”Map →

personJeffrey Kahn“Director, Johns Hopkins Berman Institute of Bioethics”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance65
How much this matters to a regular citizen
Controversy40
Intensity of disagreement among stakeholders
Entertainment20
Compellingness for a non-policy-wonk reader
Buzz15
Current news / social attention level

Publisher tools